Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
post
Last Updated on: 24 February, 2025
Author: Getaka|Social: Getaka Financial Technology X (Earlier Twitter) Profile Getaka Financial Technology LinkedIn Logo

Cyient Ltd: Share Price Analysis, Intrinsic Value & Fundamentals (2025)

Share Price and Basic Stock Data

Last Updated: February 24, 2025, 2:01 pm

Market Cap 15,019 Cr.
Current Price 1,353
High / Low 2,190/1,295
Stock P/E23.6
Book Value 463
Dividend Yield2.21 %
ROCE21.9 %
ROE18.8 %
Face Value 5.00
PEG Ratio1.68

Stock P/E, Current Price, and Intrinsic Value Over Time

View Share Price Target for Cyient Ltd

Competitors of Cyient Ltd

Stock Name ⇩Market Cap ⇩Current Price ⇩High / Low ⇩Stock P/E ⇩Book Value ⇩Dividend Yield ⇩ROCE ⇩ROE ⇩Face Value ⇩
Visesh Infotecnics Ltd 125 Cr. 0.33 0.68/0.33 1.140.00 %0.88 %0.82 % 1.00
Mudunuru Ltd 17.8 Cr. 5.72 15.6/5.51 0.340.00 %72.9 %374 % 2.00
Naapbooks Ltd 94.7 Cr. 105 159/54.040.6 20.00.00 %17.4 %13.6 % 10.0
IB Infotech Enterprises Ltd 23.4 Cr. 183 245/11330.0 16.80.55 %69.9 %50.5 % 10.0
Hit Kit Global Solutions Ltd 7.19 Cr. 1.55 1.55/0.9120.0 2.080.00 %1.92 %1.94 % 2.00
Industry Average19,414.61 Cr586.4680.38121.470.80%21.38%63.93%6.86

All Competitor Stocks of Cyient Ltd

Quarterly Result

MetricSep 2020Dec 2020Mar 2021Jun 2021Sep 2021Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023
Sales 1,0031,0441,0931,0581,1121,1831,1811,2501,3961,6181,7511,6861,778
Expenses 8458819388729049729691,0571,1921,3351,4291,3711,453
Operating Profit 158164155186207212212193205283322316326
OPM % 16%16%14%18%19%18%18%15%15%18%18%19%18%
Other Income 922402615224934-219-16-17
Interest 1012111091010163126262827
Depreciation 48494949524943516370736866
Profit before tax 109125135154162175208160108206208219240
Tax % 23%24%23%25%25%25%26%27%27%24%21%23%24%
Net Profit 849510311512113215411679156163169184
EPS in Rs 7.638.679.3710.4411.0111.9513.9810.527.1614.1214.7615.2016.10

Last Updated: Unknown

Quarterly Chart

Profit & Loss - Annual Report

Last Updated: Unknown

MetricMar 2012Mar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023TTM
Sales 1,5531,8732,2062,7363,0943,5863,9144,6184,4274,1324,5346,0166,835
Expenses 1,2841,5311,7962,3352,6803,1093,3943,9853,8813,5573,7175,0135,588
Operating Profit 2693424104014144775206335465758181,0031,247
OPM % 17%18%19%15%13%13%13%14%12%14%18%17%18%
Other Income 16361712211279147131158140112359
Interest 101616172033494339100107
Depreciation 496472718995105111188194192257276
Profit before tax 235315354446421444541620468477698681873
Tax % 36%31%29%25%24%24%26%23%27%24%25%24%
Net Profit 161231266351320340403477341364522514672
EPS in Rs 14.4820.7023.7631.4328.9430.5436.0042.3331.1433.0647.3546.5260.18
Dividend Payout % 17%22%21%25%24%34%36%35%48%51%51%56%

Profit & Loss Yearly Chart

YoY Net Profit Growth

Year2012-20132013-20142014-20152015-20162016-20172017-20182018-20192019-20202020-20212021-20222022-2023
YoY Net Profit Growth (%)43.48%15.15%31.95%-8.83%6.25%18.53%18.36%-28.51%6.74%43.41%-1.53%
Change in YoY Net Profit Growth (%)0.00%-28.33%16.80%-40.79%15.08%12.28%-0.17%-46.87%35.26%36.66%-44.94%

Cyient Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2012-2013 to 2022-2023.

Growth

Compounded Sales Growth
10 Years:12%
5 Years:9%
3 Years:20%
TTM:4%
Compounded Profit Growth
10 Years:11%
5 Years:9%
3 Years:26%
TTM:-11%
Stock Price CAGR
10 Years:9%
5 Years:26%
3 Years:19%
1 Year:-35%
Return on Equity
10 Years:17%
5 Years:16%
3 Years:18%
Last Year:19%

Last Updated: Unknown

Balance Sheet

Last Updated: November 15, 2024, 1:29 am

MonthMar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Sep 2024
Equity Capital 56565656565655555555555656
Reserves 1,2671,5321,7881,7742,0612,2882,5092,5062,9023,0613,4114,2035,085
Borrowings 061472142112833687115775731,218788570
Other Liabilities 2833565826687987739278709401,0721,8151,8831,841
Total Liabilities 1,6061,9502,5742,7133,1263,4003,8604,1424,4754,7626,5006,9287,551
Fixed Assets 3353377896577517989781,3051,3611,3452,8252,8262,904
CWIP 23710102652104146881344578
Investments 9893101160196143554134445518436417
Other Assets 1,1501,5141,6741,8862,1532,4092,7232,6502,9922,9593,1133,6094,221
Total Assets 1,6061,9502,5742,7133,1263,4003,8604,1424,4754,7626,5006,9287,551

Reserves and Borrowings Chart

Cash Flow

MonthMar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024
Cash from Operating Activity +160227362278420296370582856634554726
Cash from Investing Activity +-758-448-54-153-57-190-146-104-377-1,006-537
Cash from Financing Activity +-42-43-32-111-93-136-232-446-253-544-109-266
Net Cash Flow43193-118113174103-52-10499-287-562-77

Free Cash Flow

MonthMar 2012Mar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023
Free Cash Flow269.00342.00404.00254.00200.00266.00237.00265.00-165.00-2.00245.000.00

Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)

Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.

Free Cash Flow Chart

Financial Efficiency Indicators

MonthMar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024
Debtor Days777971726664646071596864
Inventory Days189124156160211110178228177
Days Payable599522453323347314336374260
Cash Conversion Cycle777971-337-331-233-99-76-133-99-78-19
Working Capital Days616554553953646454554956
ROCE %26%24%25%22%22%23%24%17%15%20%20%22%

Financial Efficiency Indicators Chart

Share Holding Pattern

MonthDec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024
Promoters23.41%23.41%23.40%23.37%23.36%23.35%23.35%23.20%23.20%23.17%23.16%23.15%
FIIs34.72%34.02%32.68%32.62%31.07%32.61%36.57%35.71%34.11%31.04%29.47%28.38%
DIIs22.76%23.33%23.88%23.69%24.92%24.88%21.31%21.57%22.69%25.91%27.08%29.72%
Public19.11%19.25%20.04%19.35%19.67%18.18%17.86%18.63%19.13%19.00%19.45%17.93%
Others0.00%0.00%0.00%0.98%0.98%0.98%0.92%0.90%0.89%0.88%0.84%0.82%
No. of Shareholders1,15,8661,16,2971,25,9901,24,6231,22,8521,21,5411,31,5071,45,6151,60,9211,62,0681,81,6401,82,884

Shareholding Pattern Chart

No. of Shareholders

Mutual Fund Holdings

Fund NameNo of SharesAUM (%)Amount Invested (Cr)Previous Number of SharesPrevious DatePercentage Change
DSP Small Cap Fund3,300,6974.43524.33,300,6972025-02-220%
Kotak Small Cap Fund - Regular Plan3,018,3413.94479.453,300,6972025-02-22-8.55%
DSP Mid Cap Fund2,481,3982.73394.163,300,6972025-02-22-24.82%
Nippon India Small Cap Fund2,477,1511.05393.483,300,6972025-02-22-24.95%
Aditya Birla Sun Life Digital India Fund1,152,6644.63183.093,300,6972025-02-22-65.08%
ICICI Prudential Smallcap Fund1,150,8293.05182.83,300,6972025-02-22-65.13%
Franklin India Smaller Companies Fund1,035,9111.7164.553,300,6972025-02-22-68.62%
360 ONE Focused Equity Fund889,1172.89141.233,300,6972025-02-22-73.06%
ICICI Prudential Multicap Fund571,8171.0490.833,300,6972025-02-22-82.68%
ICICI Prudential Technology Fund423,6640.6267.33,300,6972025-02-22-87.16%

ROCE Trend

EPS Trend

Key Financial Ratios

MonthMar 24Mar 23Mar 22Mar 21Mar 20
FaceValue 5.005.005.005.005.00
Basic EPS (Rs.) 62.2447.0347.7533.0831.14
Diluted EPS (Rs.) 61.7146.7147.5433.0631.14
Cash EPS (Rs.) 87.3469.7164.7250.7548.33
Book Value[Excl.RevalReserv]/Share (Rs.) 410.53313.16282.01268.49232.52
Book Value[Incl.RevalReserv]/Share (Rs.) 410.53313.16282.01268.49232.52
Revenue From Operations / Share (Rs.) 643.89543.93410.72375.67402.49
PBDIT / Share (Rs.) 123.3198.0684.2364.9964.29
PBIT / Share (Rs.) 99.2874.8666.8247.3147.22
PBT / Share (Rs.) 82.7461.5963.2643.3742.80
Net Profit / Share (Rs.) 63.3146.5147.3133.0731.25
NP After MI And SOA / Share (Rs.) 61.5146.5147.3133.0731.14
PBDIT Margin (%) 19.1518.0220.5017.2915.97
PBIT Margin (%) 15.4113.7616.2612.5911.73
PBT Margin (%) 12.8411.3215.4011.5410.63
Net Profit Margin (%) 9.838.5511.518.807.76
NP After MI And SOA Margin (%) 9.558.5511.518.807.73
Return on Networth / Equity (%) 16.0314.8316.7512.3013.37
Return on Capital Employeed (%) 20.6118.2920.9215.3716.93
Return On Assets (%) 9.747.8510.918.098.19
Long Term Debt / Equity (X) 0.060.140.000.010.03
Total Debt / Equity (X) 0.100.260.100.090.14
Asset Turnover Ratio (%) 1.050.540.450.380.46
Current Ratio (X) 2.151.582.302.572.24
Quick Ratio (X) 1.861.362.072.432.03
Inventory Turnover Ratio (X) 2.190.000.000.000.00
Dividend Payout Ratio (NP) (%) 44.8151.2056.510.0077.05
Dividend Payout Ratio (CP) (%) 32.2234.1641.310.0049.76
Earning Retention Ratio (%) 55.1948.8043.490.0022.95
Cash Earning Retention Ratio (%) 67.7865.8458.690.0050.24
Interest Coverage Ratio (X) 11.8010.8523.6616.5114.55
Interest Coverage Ratio (Post Tax) (X) 7.646.6114.299.408.07
Enterprise Value (Cr.) 21896.8611188.059314.425941.901944.95
EV / Net Operating Revenue (X) 3.061.862.051.440.43
EV / EBITDA (X) 16.0010.3210.028.312.75
MarketCap / Net Operating Revenue (X) 3.101.822.261.730.57
Retention Ratios (%) 55.1848.7943.480.0022.94
Price / BV (X) 5.203.173.292.410.98
Price / Net Operating Revenue (X) 3.101.822.261.730.57
EarningsYield 0.030.040.050.050.13

After reviewing the key financial ratios for Cyient Ltd, here is a detailed analysis based on the latest available data and recent trends:

  • For FaceValue, as of Mar 24, the value is 5.00. This value is within the healthy range. There is no change compared to the previous period (Mar 23) which recorded 5.00.
  • For Basic EPS (Rs.), as of Mar 24, the value is 62.24. This value is within the healthy range. It has increased from 47.03 (Mar 23) to 62.24, marking an increase of 15.21.
  • For Diluted EPS (Rs.), as of Mar 24, the value is 61.71. This value is within the healthy range. It has increased from 46.71 (Mar 23) to 61.71, marking an increase of 15.00.
  • For Cash EPS (Rs.), as of Mar 24, the value is 87.34. This value is within the healthy range. It has increased from 69.71 (Mar 23) to 87.34, marking an increase of 17.63.
  • For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 24, the value is 410.53. It has increased from 313.16 (Mar 23) to 410.53, marking an increase of 97.37.
  • For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 24, the value is 410.53. It has increased from 313.16 (Mar 23) to 410.53, marking an increase of 97.37.
  • For Revenue From Operations / Share (Rs.), as of Mar 24, the value is 643.89. It has increased from 543.93 (Mar 23) to 643.89, marking an increase of 99.96.
  • For PBDIT / Share (Rs.), as of Mar 24, the value is 123.31. This value is within the healthy range. It has increased from 98.06 (Mar 23) to 123.31, marking an increase of 25.25.
  • For PBIT / Share (Rs.), as of Mar 24, the value is 99.28. This value is within the healthy range. It has increased from 74.86 (Mar 23) to 99.28, marking an increase of 24.42.
  • For PBT / Share (Rs.), as of Mar 24, the value is 82.74. This value is within the healthy range. It has increased from 61.59 (Mar 23) to 82.74, marking an increase of 21.15.
  • For Net Profit / Share (Rs.), as of Mar 24, the value is 63.31. This value is within the healthy range. It has increased from 46.51 (Mar 23) to 63.31, marking an increase of 16.80.
  • For NP After MI And SOA / Share (Rs.), as of Mar 24, the value is 61.51. This value is within the healthy range. It has increased from 46.51 (Mar 23) to 61.51, marking an increase of 15.00.
  • For PBDIT Margin (%), as of Mar 24, the value is 19.15. This value is within the healthy range. It has increased from 18.02 (Mar 23) to 19.15, marking an increase of 1.13.
  • For PBIT Margin (%), as of Mar 24, the value is 15.41. This value is within the healthy range. It has increased from 13.76 (Mar 23) to 15.41, marking an increase of 1.65.
  • For PBT Margin (%), as of Mar 24, the value is 12.84. This value is within the healthy range. It has increased from 11.32 (Mar 23) to 12.84, marking an increase of 1.52.
  • For Net Profit Margin (%), as of Mar 24, the value is 9.83. This value is within the healthy range. It has increased from 8.55 (Mar 23) to 9.83, marking an increase of 1.28.
  • For NP After MI And SOA Margin (%), as of Mar 24, the value is 9.55. This value is within the healthy range. It has increased from 8.55 (Mar 23) to 9.55, marking an increase of 1.00.
  • For Return on Networth / Equity (%), as of Mar 24, the value is 16.03. This value is within the healthy range. It has increased from 14.83 (Mar 23) to 16.03, marking an increase of 1.20.
  • For Return on Capital Employeed (%), as of Mar 24, the value is 20.61. This value is within the healthy range. It has increased from 18.29 (Mar 23) to 20.61, marking an increase of 2.32.
  • For Return On Assets (%), as of Mar 24, the value is 9.74. This value is within the healthy range. It has increased from 7.85 (Mar 23) to 9.74, marking an increase of 1.89.
  • For Long Term Debt / Equity (X), as of Mar 24, the value is 0.06. This value is below the healthy minimum of 0.2. It has decreased from 0.14 (Mar 23) to 0.06, marking a decrease of 0.08.
  • For Total Debt / Equity (X), as of Mar 24, the value is 0.10. This value is within the healthy range. It has decreased from 0.26 (Mar 23) to 0.10, marking a decrease of 0.16.
  • For Asset Turnover Ratio (%), as of Mar 24, the value is 1.05. It has increased from 0.54 (Mar 23) to 1.05, marking an increase of 0.51.
  • For Current Ratio (X), as of Mar 24, the value is 2.15. This value is within the healthy range. It has increased from 1.58 (Mar 23) to 2.15, marking an increase of 0.57.
  • For Quick Ratio (X), as of Mar 24, the value is 1.86. This value is within the healthy range. It has increased from 1.36 (Mar 23) to 1.86, marking an increase of 0.50.
  • For Inventory Turnover Ratio (X), as of Mar 24, the value is 2.19. This value is below the healthy minimum of 4. It has increased from 0.00 (Mar 23) to 2.19, marking an increase of 2.19.
  • For Dividend Payout Ratio (NP) (%), as of Mar 24, the value is 44.81. This value is within the healthy range. It has decreased from 51.20 (Mar 23) to 44.81, marking a decrease of 6.39.
  • For Dividend Payout Ratio (CP) (%), as of Mar 24, the value is 32.22. This value is within the healthy range. It has decreased from 34.16 (Mar 23) to 32.22, marking a decrease of 1.94.
  • For Earning Retention Ratio (%), as of Mar 24, the value is 55.19. This value is within the healthy range. It has increased from 48.80 (Mar 23) to 55.19, marking an increase of 6.39.
  • For Cash Earning Retention Ratio (%), as of Mar 24, the value is 67.78. This value is within the healthy range. It has increased from 65.84 (Mar 23) to 67.78, marking an increase of 1.94.
  • For Interest Coverage Ratio (X), as of Mar 24, the value is 11.80. This value is within the healthy range. It has increased from 10.85 (Mar 23) to 11.80, marking an increase of 0.95.
  • For Interest Coverage Ratio (Post Tax) (X), as of Mar 24, the value is 7.64. This value is within the healthy range. It has increased from 6.61 (Mar 23) to 7.64, marking an increase of 1.03.
  • For Enterprise Value (Cr.), as of Mar 24, the value is 21,896.86. It has increased from 11,188.05 (Mar 23) to 21,896.86, marking an increase of 10,708.81.
  • For EV / Net Operating Revenue (X), as of Mar 24, the value is 3.06. This value exceeds the healthy maximum of 3. It has increased from 1.86 (Mar 23) to 3.06, marking an increase of 1.20.
  • For EV / EBITDA (X), as of Mar 24, the value is 16.00. This value exceeds the healthy maximum of 15. It has increased from 10.32 (Mar 23) to 16.00, marking an increase of 5.68.
  • For MarketCap / Net Operating Revenue (X), as of Mar 24, the value is 3.10. This value exceeds the healthy maximum of 3. It has increased from 1.82 (Mar 23) to 3.10, marking an increase of 1.28.
  • For Retention Ratios (%), as of Mar 24, the value is 55.18. This value is within the healthy range. It has increased from 48.79 (Mar 23) to 55.18, marking an increase of 6.39.
  • For Price / BV (X), as of Mar 24, the value is 5.20. This value exceeds the healthy maximum of 3. It has increased from 3.17 (Mar 23) to 5.20, marking an increase of 2.03.
  • For Price / Net Operating Revenue (X), as of Mar 24, the value is 3.10. This value exceeds the healthy maximum of 3. It has increased from 1.82 (Mar 23) to 3.10, marking an increase of 1.28.
  • For EarningsYield, as of Mar 24, the value is 0.03. This value is below the healthy minimum of 5. It has decreased from 0.04 (Mar 23) to 0.03, marking a decrease of 0.01.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation. If you have any questions or need more detailed insights, please feel free to reach out.

Profitability Ratios (%)

Liquidity Ratios

Liquidity Ratios (%)

Interest Coverage Ratios (%)

Valuation Ratios

Fair Value

Fair Value of Cyient Ltd as of February 24, 2025 is: ₹1,679.71

Calculation basis:

  • Fair value = P/E Ratio * (Return on Equity / 100) * Book Value * (1 + Dividend Yield / 100)
  • P/E Ratio (Price-to-Earnings Ratio): Represents the price of the stock relative to its earnings per share. A higher P/E ratio indicates that investors are willing to pay a higher price for the stock.
  • Return on Equity (ROE): Measures a company's profitability relative to its shareholder equity. It showcases the company's ability to generate profits using the investment made by its shareholders, offering valuable insight into its operational efficiency and financial performance.
  • Book Value: Represents the net asset value of the company per share. It is calculated as the total assets minus intangible assets and liabilities, divided by the number of outstanding shares.
  • Dividend Yield: The ratio of the annual dividend per share to the current market price per share. It offers valuable insights into the profitability of an investment through dividends.

This formula allows us to gauge the fair value of the stock by analyzing its fundamental indicators.

As of February 24, 2025, Cyient Ltd is Undervalued by 24.15% compared to the current share price ₹1,353.00

Intrinsic Value of Cyient Ltd as of February 24, 2025 is: 1,916.29

Calculation basis:

  • Intrinsic value = P/E Ratio * (Return on Equity / 100) * Book Value * (1 + Dividend Yield / 100) * (1 + EPS CAGR for Last 5 Years)
  • P/E Ratio (Price-to-Earnings Ratio): Represents the price of the stock relative to its earnings per share. A higher P/E ratio indicates that investors are willing to pay a higher price for the stock.
  • Return on Equity (ROE): Measures a company's profitability relative to its shareholder equity. It showcases the company's ability to generate profits using the investment made by its shareholders, offering valuable insight into its operational efficiency and financial performance.
  • Book Value: Represents the net asset value of the company per share. It is calculated as the total assets minus intangible assets and liabilities, divided by the number of outstanding shares.
  • Dividend Yield: The ratio of the annual dividend per share to the current market price per share. It offers valuable insights into the profitability of an investment through dividends.
  • EPS CAGR (Compound Annual Growth Rate): Represents the geometric mean growth rate of earnings per share over the last 5 years. It provides insight into the historical growth trajectory of the company's earnings.

This formula allows us to gauge the intrinsic value of the stock by analyzing its fundamental indicators along with EPS growth.

As of February 24, 2025, Cyient Ltd is Undervalued by 41.63% compared to the current share price ₹1,353.00

Last 5 Year EPS CAGR: 14.08%

*Investments are subject to market risks

Strength and Weakness

StrengthWeakness
  1. The stock has a high average ROCE of 21.67%, which is a positive sign.
  2. The stock has a low average Cash Conversion Cycle of -98.17, which is a positive sign.
  3. The company has higher reserves (2,645.15 cr) compared to borrowings (435.85 cr), indicating strong financial stability.
  4. The company has shown consistent growth in sales (3.31 cr) and profit (505.62 cr) over the years.
  1. The stock has a high average Working Capital Days of 55.75, which may not be favorable.

Stock Analysis

  • Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Cyient Ltd:
    1. Net Profit Margin: 9.83%
      • Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
    2. ROCE: 20.61% (Industry Average ROCE: 20.58%)
      • ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
    3. ROE%: 16.03% (Industry Average ROE: 59.71%)
      • ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
    4. Interest Coverage Ratio (Post Tax): 7.64
      • Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
    5. Quick Ratio: 1.86
      • Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
    6. Stock P/E: 23.6 (Industry average Stock P/E: 63.7)
      • Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
    7. Total Debt / Equity: 0.1
      • Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
    The current analysis is available for review. It's important to conduct thorough research and consider consulting with financial professionals before making any investment decisions.
    Stock Rating:

About the Company - Qualitative Analysis

Cyient Ltd. is a Public Limited Listed company incorporated on 28/08/1991 and has its registered office in the State of Telangana, India. Company's Corporate Identification Number(CIN) is L72200TG1991PLC013134 and registration number is 013134. Currently Company is involved in the business activities of Other information technology and computer service activities n.e.c. Company's Total Operating Revenue is Rs. 2461.40 Cr. and Equity Capital is Rs. 55.50 Cr. for the Year ended 31/03/2024.
INDUSTRYADDRESSCONTACT
IT Consulting & Software4th Floor, �A� Wing, Hyderabad Telangana 500081company.secretary@cyient.com
http://www.cyient.com
Management
NamePosition Held
Mr. B V R Mohan ReddyFounder Chairman
Mr. M M MurugappanNon Executive Chairman
Mr. Krishna BodanapuExec. Vice Chairman & Mang Dir
Mr. Karthikeyan NatarajanExecutive Director & CEO
Ms. Matangi GowrishankarIndependent Director
Mr. Vikas SehgalIndependent Director
Mr. Vivek Narayan GouirIndependent Director
Mr. Nitin PrasadIndependent Director

FAQ

What is the latest intrinsic value of Cyient Ltd?

Let's break down Cyient Ltd's intrinsic value simply:

We calculate intrinsic value using the PE Ratio Method - comparing the company's current price-to-earnings ratio with its historical average and industry peers. Think of it like checking if a stock is "on sale" compared to its typical pricing.

As of 24 February 2025:

  • Calculated Fair Value: ₹1679.71
  • Current Market Price: ₹1,353.00
  • Variance: 24.15% higher

This suggests Cyient Ltd is currently undervalued by 24.15%. For context:

  • Market Cap: 15,019 Cr.
  • 52-Week Range: 2,190/1,295
  • Reserves (Sep 2024): ₹5,085 Cr
  • Liabilities: 7,551 Cr

Remember: The PE method gives a snapshot based on earnings multiples. While useful for quick comparisons, investors should also consider growth prospects, industry trends, and economic conditions. This calculation assumes historical PE ratios remain relevant - always verify with current market dynamics.

What is the Market Cap of Cyient Ltd?

The Market Cap of Cyient Ltd is 15,019 Cr..

What is the current Stock Price of Cyient Ltd as on 24 February 2025?

The current stock price of Cyient Ltd as on 24 February 2025 is ₹1,353.

What is the High / Low of Cyient Ltd stocks in FY 2024-2025?

In FY 2024-2025, the High / Low of Cyient Ltd stocks is 2,190/1,295.

What is the Stock P/E of Cyient Ltd?

The Stock P/E of Cyient Ltd is 23.6.

What is the Book Value of Cyient Ltd?

The Book Value of Cyient Ltd is 463.

What is the Dividend Yield of Cyient Ltd?

The Dividend Yield of Cyient Ltd is 2.21 %.

What is the ROCE of Cyient Ltd?

The ROCE of Cyient Ltd is 21.9 %.

What is the ROE of Cyient Ltd?

The ROE of Cyient Ltd is 18.8 %.

What is the Face Value of Cyient Ltd?

The Face Value of Cyient Ltd is 5.00.

Disclaimer: This article is for informational purposes only and should not be construed as financial advice. The author is not a SEBI registered financial advisor and does not have any vested interest in Cyient Ltd. Investors are advised to conduct their own due diligence and consult with a financial professional before making any investment decisions. The information provided in this article is based on publicly available data and the author's analysis, but it may not be comprehensive or up-to-date. The author and getaka.co.in are not responsible for any errors or omissions in the content. This article is not intended to promote any particular investment strategy or recommendation, and readers should consult with their own financial advisors before making any investment decisions. Data Source: NSE